Do analysts prefer ACB or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend OGI or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Do analysts prefer OGI or CRON?

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 16.36%. Given Cronos Group's higher possible upside, analysts clearly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Do analysts prefer SNDL or OGI?

SNDL presently has a consensus target price of $5.00, indicating a potential upside of 281.68%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has preferable earnings & valuation, SNDL or OGI?

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.50 -$11.29M -$0.03 N/A Organigram Global $185.07M 0.68 -$17.70M -$0.13 N/A

Is SNDL or OGI more profitable?

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity. Company Net Margins Return on Equity Return on Assets SNDL -1.19% -1.02% -0.85% Organigram Global -9.22% -13.41% -9.09%

Do analysts recommend TLRY or OGI?

Tilray Brands currently has a consensus target price of $11.50, suggesting a potential upside of 157.85%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Organigram Global (OGI) Competitors

$0.90 -0.07 (-7.32%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$0.91 +0.01 (+1.59%)

As of 07/13/2026 07:54 PM Eastern

Compare

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? MarketBeat compares Organigram Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Organigram Global compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Aurora Cannabis had 5 more articles in the media than Organigram Global. MarketBeat recorded 6 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.89 beat Aurora Cannabis' score of 0.24 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
Organigram Global	Very Positive

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Comparatively, 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Organigram Global has lower revenue, but higher earnings than Aurora Cannabis. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.66	-$88.13M	-$1.56	N/A
Organigram Global	$185.07M	0.68	-$17.70M	-$0.13	N/A

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
Organigram Global	-9.22%	-13.41%	-9.09%

Aurora Cannabis has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market.

Summary

Organigram Global beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Organigram Global (NASDAQ:OGI) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Organigram Global has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market.

In the previous week, Canopy Growth had 6 more articles in the media than Organigram Global. MarketBeat recorded 7 mentions for Canopy Growth and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.89 beat Canopy Growth's score of 1.10 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Very Positive
Canopy Growth	Positive

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -75.27%. Organigram Global's return on equity of -13.41% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Canopy Growth	-75.27%	-26.95%	-17.20%

Organigram Global has higher earnings, but lower revenue than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.68	-$17.70M	-$0.13	N/A
Canopy Growth	$251.01M	1.72	-$190.29M	-$0.59	N/A

Summary

Organigram Global beats Canopy Growth on 9 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Organigram Global has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Cronos Group	-1.14%	-1.26%	-1.20%

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.68	-$17.70M	-$0.13	N/A
Cronos Group	$146.59M	7.00	-$9.45M	$0.01	275.00

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 16.36%. Given Cronos Group's higher possible upside, analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Organigram Global and Organigram Global both had 1 articles in the media. Organigram Global's average media sentiment score of 1.89 beat Cronos Group's score of 0.96 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Very Positive
Cronos Group	Positive

Summary

Cronos Group beats Organigram Global on 9 of the 14 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

SNDL (NASDAQ:SNDL) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

SNDL has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

34.6% of Organigram Global shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, SNDL and SNDL both had 1 articles in the media. Organigram Global's average media sentiment score of 1.89 beat SNDL's score of 1.87 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
SNDL	Very Positive
Organigram Global	Very Positive

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.50	-$11.29M	-$0.03	N/A
Organigram Global	$185.07M	0.68	-$17.70M	-$0.13	N/A

SNDL presently has a consensus target price of $5.00, indicating a potential upside of 281.68%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Organigram Global	-9.22%	-13.41%	-9.09%

Summary

Organigram Global beats SNDL on 8 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Organigram Global is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.63	-$2.19B	-$13.65	N/A
Organigram Global	$185.07M	0.68	-$17.70M	-$0.13	N/A

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.8% of Tilray Brands shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Organigram Global has a net margin of -9.22% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Organigram Global	-9.22%	-13.41%	-9.09%

Tilray Brands has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, suggesting that its stock price is 45% more volatile than the broader market.

Tilray Brands currently has a consensus target price of $11.50, suggesting a potential upside of 157.85%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Tilray Brands had 22 more articles in the media than Organigram Global. MarketBeat recorded 23 mentions for Tilray Brands and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.89 beat Tilray Brands' score of 0.78 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Positive
Organigram Global	Very Positive

Summary

Tilray Brands beats Organigram Global on 9 of the 16 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OGI vs. The Competition

Export

Metric	Organigram Global	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$136.11M	$8.82B	$7.05B	$12.61B
Dividend Yield	N/A	2.54%	2.68%	8.00%
P/E Ratio	-6.89	16.09	27.11	24.26
Price / Sales	0.68	7.04	587.92	117.88
Price / Cash	N/A	18.40	29.22	49.36
Price / Book	0.48	3.57	10.75	6.29
Net Income	-$17.70M	$228.19M	$3.58B	$330.66M
7 Day Performance	-7.43%	-2.31%	-2.06%	-1.32%
1 Month Performance	-15.49%	-0.62%	3.32%	-0.64%
1 Year Performance	-39.47%	-2.73%	26.36%	19.08%

Organigram Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OGI Organigram Global	1.4543 of 5 stars	$0.90 -7.3%	N/A	-38.2%	$136.11M	$185.07M	N/A	1,139	Positive News High Trading Volume
ACB Aurora Cannabis	1.3295 of 5 stars	$2.67 -1.5%	N/A	-40.5%	$163.78M	$247.82M	N/A	1,028
CGC Canopy Growth	1.3239 of 5 stars	$0.95 -1.0%	N/A	-15.0%	$426.00M	$251.01M	N/A	1,128	Positive News
CRON Cronos Group	1.6134 of 5 stars	$2.75 -0.4%	$2.30 -16.4%	+31.6%	$1.03B	$146.59M	275.28	450
SNDL SNDL	4.2232 of 5 stars	$1.30 flat	$5.00 +284.6%	-5.8%	$334.62M	$677.32M	N/A	2,751	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OGI) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Summary

How does Organigram Global compare to Canopy Growth?

Summary

How does Organigram Global compare to Cronos Group?

Summary

How does Organigram Global compare to SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Do analysts prefer ACB or OGI?

Does the media prefer ACB or OGI?

Do insiders & institutionals believe in ACB or OGI?

Which has better earnings and valuation, ACB or OGI?

Is ACB or OGI more profitable?

Which has more volatility & risk, ACB or OGI?

Summary

How does Organigram Global compare to Canopy Growth?

Do analysts recommend OGI or CGC?

Which has more volatility & risk, OGI or CGC?

Does the media refer more to OGI or CGC?

Do institutionals & insiders hold more shares of OGI or CGC?

Is OGI or CGC more profitable?

Which has preferable earnings & valuation, OGI or CGC?

Summary

How does Organigram Global compare to Cronos Group?

Do insiders & institutionals hold more shares of OGI or CRON?

Which has more volatility & risk, OGI or CRON?

Is OGI or CRON more profitable?

Which has stronger earnings and valuation, OGI or CRON?

Do analysts prefer OGI or CRON?

Does the media favor OGI or CRON?

Summary

How does Organigram Global compare to SNDL?

Which has more volatility and risk, SNDL or OGI?

Do insiders and institutionals believe in SNDL or OGI?

Does the media favor SNDL or OGI?

Which has preferable earnings & valuation, SNDL or OGI?

Do analysts prefer SNDL or OGI?

Is SNDL or OGI more profitable?

Summary

How does Organigram Global compare to Tilray Brands?

Which has stronger earnings & valuation, TLRY or OGI?

Do institutionals and insiders hold more shares of TLRY or OGI?

Is TLRY or OGI more profitable?

Which has more volatility and risk, TLRY or OGI?

Do analysts recommend TLRY or OGI?

Does the media prefer TLRY or OGI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools